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Abstract
Objectives—We examined the association between health insurance and survival of infants with 
congenital heart defects (CHDs), and whether medical insurance type contributed to racial/ethnic 
disparities in survival.
Methods—We conducted a population-based, retrospective study on a cohort of Florida resident 
infants born with CHDs between 1998 and 2007. We estimated neonatal, post-neonatal, and infant 
survival probabilities and adjusted hazard ratios (AHRs) for individual characteristics.
Results—Uninsured infants with critical CHDs had 3 times the mortality risk (AHR = 3.0; 95% 
confidence interval = 1.3, 6.9) than that in privately insured infants. Publicly insured infants had a 
30% reduced mortality risk than that of privately insured infants during the neonatal period, but 
had a 30% increased risk in the post-neonatal period. Adjusting for insurance type reduced the 
Black–White disparity in mortality risk by 50%.
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Conclusions—Racial/ethnic disparities in survival were attenuated significantly, but not 
eliminated, by adjusting for payer status. (Am J Public Health2014;104: e62–e70. doi:10.2105/
AJPH.2014.301969)
Major health care reform efforts have sought to improve access to health care by reducing 
barriers associated with the lack of or insufficient insurance coverage.1,2 Although literature 
exists on the impact of insurance coverage on health care utilization, there is a relative 
dearth of population-based evidence on whether insurance coverage is associated with 
significant health outcomes, particularly among the most medically vulnerable groups, 
which includes children with birth defects.
Infants born with congenital heart defects (CHDs), the most common birth defect and 
leading cause of death among those born with birth defects, often require timely specialized 
surgical and medical care3–5; therefore, access to care and service utilization may be 
important predictors of survival. Although recent advances in surgical interventions have 
resulted in improved survival rates among infants born with CHDs, mortality remains a 
significant public health problem, and unexplained racial/ethnic disparities add health equity 
concerns.6–9 These racial/ethnic disparities in survival suggest that identification of 
contributing factors could potentially lead to effective strategies to reduce CHD-related 
infant and childhood mortality, which has been identified as a national public health priority 
by Healthy People 2020.10
Some hospital-based studies have found positive associations between insurance type and 
postoperative mortality of infants with CHDs.6,8,11–14 Population-based birth defects 
surveillance programs provide the most complete ascertainment of infants born with major 
birth defects in a population that, when linked with vital records, provide a more complete 
source of case data for survival studies. However, most published population-based studies 
have had only a limited ability to examine factors associated with survival.15–22 Despite the 
high sensitivity and accuracy of surveillance data,23 payer information is not typically 
available beyond that reported on the birth certificate.
We used population-based birth defects surveillance data, which were linked with data for 
each hospitalization, to obtain information on the type of health insurance used for 
hospitalizations initiated during the first year of life. Using these unique data, we examined 
the association between survival and health insurance type, and the association of health 
insurance type on racial/ethnic disparities in survival of infants born with CHDs.
METHODS
Our study was a retrospective, population-based cohort study of infants born in Florida from 
January 1, 1998, through December 31, 2007. Eligible infants were those born alive to a 
Florida resident mother during the study period and identified by the Florida Birth Defects 
Registry (FBDR) as having a CHD as determined by International Classification of Disease, 
Ninth Revision, Clinical Modification codes 745.0–747.49.24 All those infants without a 
matched death certificate were assumed to be alive at the end of the study. Age at death 
(days) was determined by the number of days from birth date to death date on a death 
certificate, determined by subtracting the birth date from the date of death. Information 
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about each infant’s hospitalizations was collected and reported by participating hospitals to 
the Florida Agency for Health Care Administration (AHCA) as required by Florida law. The 
relevant AHCA data included inpatient hospital discharge information, including 
demographic characteristics, diagnostic coding, procedural codes, and principal payer 
information.25–27 Exclusion criteria for the FBDR included out-of-state deliveries, and any 
adopted and prospective adopted infants. Because gestational age at less than 23 weeks often 
results in high mortality regardless of medical intervention, we excluded these infants from 
the analyses. Similarly, we also excluded those with chromosomal abnormalities because of 
the high fatality rate, with the exception of those with Down syndrome. Survival of infants 
with Down syndrome has improved significantly in recent years, particularly among those 
with CHDs, and the survival of infants with co-occurring Down syndrome and CHDs is 
similar to that for infants with only CHDs.16,28 In our cohort, infants with Down syndrome 
had a 1-year survival similar to those with isolated CHDs (95% vs 97%, respectively) and 
was better than those with a CHD and non-chromosomal birth defects (88%).
Variables
We determined the primary independent variable, health insurance payer type, by the 
reported expected principal payer for any inpatient admission during infancy and classified 
it into 3 categories: (1) private, including military coverage (CHAMPUS/TriCare); (2) 
public, including Medicare, Medicaid, KidCare, and veterans benefits; and (3) no insurance, 
self-pay, or underinsured, which was defined as no third party coverage or less than 30% 
estimated insurance coverage. For brevity, the uninsured, underinsured, and self-pay group 
is hereafter referred to as uninsured. We determined final insurance status for each infant by 
assessing changes to the payer type across all admissions during infancy and classified 
insurance status in 1 of 4 insurance coverage categories: private only, public only, uninsured 
only, or a mix (more than 1 type of payer). We determined the level of neonatal care at the 
birth hospital from the AHCA data and classified it as levels I to III, with level III 
representing the highest level of intensity and specialization of care.29 For those infants who 
were transferred directly from the birth hospital to another facility, we analyzed the facility 
with the higher level of care.
FBDR matched case data with Florida vital records to obtain the demographic 
characteristics, which included maternal race/ethnicity (non-Hispanic [NH] White, NH 
Black, Hispanic, and other); maternal nativity, age, and education; the Adequacy of Prenatal 
Care Utilization Index, which is a measure of the adequacy of both initiation of and the of 
receipt prenatal care services (inadequate vs adequate)30; and infant sex, birth weight, 
gestational age, and plurality.
We used clinical information from the FBDR to identify the presence of CHDs and any 
additional noncardiac birth defects. Infants with critical CHDs require surgical or catheter 
intervention in the first year of life and are at risk for cardiovascular collapse or death if 
discharged from the birth hospital without a critical CHD diagnosis.31To examine whether 
the association between insurance and survival was stronger among those requiring more 
medical services, we classified infants with any of the following subtypes of CHD as having 
at least 1 critical CHD: hypoplastic left heart syndrome, pulmonary atresia, complete 
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transposition of the great arteries, truncus arteriosus, tricuspid atresia, tetralogy of Fallot, 
total anomalous pulmonary venous return, coarctation of the aorta, doublet outlet right 
ventricle, Ebstein anomaly, interrupted aortic arch, and single ventricle.31
Analysis
We estimated infant survival probabilities by the Kaplan-Meier product-limit method,32 and 
Greenwood’s method was used to calculate the estimated survival probability variance and 
95% confidence intervals (CIs).33 We used a bivariate log-rank test to determine whether the 
survival probabilities were significantly different among nonmissing levels of maternal race/
ethnicity, insurance status, and other covariates described previously.34 Kaplan-Meier 
curves were visually examined to assess the survival distribution across infancy. We used 
Cox proportional hazard models to estimate unadjusted and adjusted hazard ratios (AHRs) 
for possible factors for the neonatal period (< 28 days) and post-neonatal (28–364 days) 
period, which were estimated assuming survival through the neonatal period.34 Because 
maternal nativity was correlated with race/ethnicity and prenatal care had a high number of 
missing values, we dropped these variables from the model. All other variables had < 2% 
missing data. We also examined potential trends in the survival estimates across the study 
period. To identify confounders with the most influence, we grouped covariates into clinical, 
demographic, and health care categories. Separate models were run for each category. The 
effect of secular trends on the association between survival and payer type were examined. 
We used SAS-PC version 9.2 (SAS Institute, Cary, NC) for the computations.
RESULTS
Of the 45 144 infants identified with CHDs, 917 infants (2%) were unable to be linked with 
AHCA data, and 816 infants were excluded because of a gestational age of less than 23 
weeks or chromosomal abnormalities other than Down syndrome. Of the final study 
population (n = 43 411), 46.1% of infants had private insurance, 44.3% had public 
insurance, 3.3% were uninsured, and 6.3% had a mix of payers during the first year of life 
(Table 1). Infants with at least 1 critical CHD were 8.5% (n = 3683) of the total cohort 
(Table 2).
Survival Estimates
The overall 1-year survival of infants with any CHD was 96.7% (95% CI = 96.5, 96.8) and 
was 85.3% (95% CI = 84.1, 86.4) in those with a critical CHD. Overall infant survival 
varied by maternal race/ethnicity, with Hispanics having the best survival (98.1%), followed 
by other race/ethnicity (96.9%), NH Whites (96.5%), and NH Blacks (95.3%; P < .001; 
Table 2). The Kaplan-Meier survival curves by race/ethnicity indicated that racial/ethnic 
disparities increased with increasing age through infancy, and racial/ethnic disparities were 
greater in infants with critical CHDs compared with those with noncritical CHDs (Figure A, 
available as a supplement to the online version of this article at http://www.ajph.org).
Infant survival varied by insurance coverage in the bivariate analysis (P < .001), and the 
Kaplan-Meier survival curves showed that the impact of insurance coverage on survival 
differed by CHD type and infant’s age (Figure 1). Although they represented approximately 
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3% of the entire cohort, uninsured infants had poorer survival in early infancy, and this 
survival disadvantage was considerably greater among infants with critical CHDs (Figure 1).
Because the distribution of insurance type varied by race/ethnicity (i.e., non-Whites were 
more likely to be on public insurance), racial/ethnic disparities were examined within each 
insurance category. In both the private and public insurance categories, NH Blacks had 
poorer survival compared with Hispanic and NH Whites (P < .004); however, NH Whites 
had the lowest survival among uninsured infants (Figure B, available as a supplement to the 
online version of this article at http://www.ajph.org). Hispanics had the best survival for all 
categories of insurance, and a subanalysis showed moderate yet statistically significant (P 
< .001; α = 0.05) differences in infant survival in the Hispanic subgroup, with Cubans 
having the highest (99.0%) and Mexicans having the lowest (96.8%) survival (data not 
shown).
Hazard Models
Compared with private insurance, public insurance was associated with a 30% lower risk of 
death during the neonatal period and a 30% higher mortality risk in the post-neonatal period 
(Table 3). Uninsured infants with critical and noncritical CHDs had approximately 3 times 
and 2 times the increased neonatal mortality risk, respectively, compared with infants with 
private insurance. The 3 times increased neonatal mortality risk in infants with critical 
CHDs was largely driven by the 5 times and 6 times increased neonatal mortality among NH 
White and Hispanic infants, respectively. The mortality risk of those with mixed insurance 
was very similar to those on public insurance, a finding that was largely consistent across 
CHD types and racial/ethnic categories. The public–private survival difference was most 
notable among NH Blacks, particularly among NH Blacks with critical CHDs for whom the 
private–public mortality risk difference was greatest between the neonatal and post-neonatal 
periods. Among NH Black infants with critical CHDs, those with public insurance had a 
70% reduced risk of death in the neonatal period compared with privately insured infants, 
but they also had a 2 times increased risk in the post-neonatal period. No change in survival 
over time was observed among noncritical CHDs; however, infant survival improved among 
critical CHDs from 84.7% in 1998 to 88.9% in 2007 (data not shown). A post hoc analysis 
included the addition of a variable for birth year in the models, and this inclusion did not 
change the mortality risk associated with insurance type.
After adjustment for factors for which survival varied in the crude survival analysis, infants 
born to NH Black mothers had a 20% higher mortality risk during the post-neonatal period 
than that of infants born to NH White mothers. There was no Black–White survival disparity 
in the neonatal period. Infants born to Hispanic mothers were 40% less likely to die in the 
post-neonatal period than infants born to NH White mothers. This difference in post-
neonatal mortality was not notably attenuated by adjustment for potential confounders (data 
available as a supplement to the online version of this article at http://www.ajph.org). 
Adjusting only for factors related to health care (birth hospital level of care and insurance 
status) had the greatest reduction of the observed crude post-neonatal Black–White 
disparity, attenuating the excess Black mortality risk by 63% (data available as a supplement 
to the online version of this article at http://www.ajph.org).
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The type of health insurance coverage of infants born with CHDs was associated with 
differences in infant survival, and the magnitude of the association varied by maternal race/
ethnicity, CHD type, and infancy period. The most vulnerable group was infants with 
critical CHDs who had no insurance or who were underinsured. Although small in numbers, 
this group was 3 times more likely to die in the neonatal period than privately insured 
infants with critical CHDs. Infants with public insurance had a modestly reduced risk of 
death during the neonatal period compared with infants with private insurance, but 
experienced an increasing excess mortality risk throughout the post-neonatal period. Type of 
health insurance and level of neonatal care use accounted for more of the observed racial 
differences in mortality between NH Blacks and NH Whites than did other demographic 
characteristics and clinical factors. However, a higher infant mortality risk among NH 
Blacks persisted even after accounting for potential confounders. Also, for each type of 
insurance, Hispanics had the lowest infant mortality.
A surprising and somewhat paradoxical finding was the changing public–private mortality 
risk across infancy periods. Infants with public insurance had lower mortality risk during the 
neonatal period and an increased mortality risk in the post-neonatal period. Children on 
public insurance were shown to have poorer access to specialty care compared with 
privately insured children, and would be expected to be at greater risk,35 so reasons why 
publicly insured infants with CHDs had better neonatal survival are not clear. One potential 
explanation could be that publicly insured women with CHD-affected fetuses were 
considered high risk and were more vigilantly referred to specialty care. If true, it be might 
be expected that this effect would be observed among only or more strongly for infants with 
critical CHDs, which were more likely to be detected prenatally.36 Yet, the survival benefit 
in our study was present nearly equally among infants with critical and noncritical CHDs.
Although approximately 3% of the cohort was uninsured, this group had the greatest risk for 
neonatal mortality compared with infants with private insurance, and this risk difference was 
highest among infants with critical CHDs. A published review of the literature that 
examined access to medical care by children with special health care needs documented a 
consistent negative association between having no insurance and accessing specialty care 
both in terms of frequency of use and delays in obtaining care.35 Perlstein et al. found that 
uninsured infants with CHDs were referred to pediatric cardiologists later than those with 
insurance,37 and Chang et al. found an increasing trend in the age of surgical repair of select 
CHDs for infants with private, managed care, and public insurance.38 Although lack of 
insurance was shown to be associated with mortality among infants of very low birth 
weight,39 ours was the first study that observed that association among infants with CHDs.
The Black–White disparities in survival observed in our study were consistent with most 
infant7,9,40 and in-hospital mortality studies,6,8,41 but not all.42 We corroborated previous 
work that demonstrated that racial/ethnic disparities were more apparent in the post-neonatal 
period and widened with increasing age,16 suggesting that studies that presented only overall 
infant survival might mask racial/ethnic disparities because a large proportion of deaths 
occur in the neonatal period, during which disparities were not as evident. Survival 
Kucik et al. Page 6













differences between Hispanics and NH Whites were less consistently reported. Although we 
observed improved infant survival among Hispanics, previous studies did not note a survival 
advantage.7,42 A subanalysis of our population found statistically significant heterogeneity 
across Hispanic groups, possibly because of the unique composition of the Hispanic 
population in Florida, which might limit the generalizability to other states.
Our study found that indicators related to access to care, whether potential (health insurance) 
or realized (birth in hospitals with more specialized services),43 accounted for more of the 
racial/ethnic disparities than other measured indicators. Health insurance and other access to 
care indicators accounted for approximately two thirds of the excess mortality risk among 
NH Blacks, yet some unexplained increased risk remained. Additional work to examine 
referral patterns and the potential that NH Blacks might be referred to hospitals with a 
record of higher mortality might further explain the observed racial/ethnic disparities in 
survival.39,44,45
Study Limitations
Although we used population-based birth defects surveillance data, several limitations 
should be considered. In contrast to active ascertainment that involves program staff actively 
searching data sources and abstracting information from medical records, the FBDR used 
passive case ascertainment that relied on administrative data from multiple data sources to 
identify infants with CHDs and other birth defects. These methods were less comprehensive 
than active ascertainment used by a limited number of other state-based programs,46 and 
might produce less accurate birth prevalence estimates.47–49 In addition, the 2% of infants 
with CHDs identified by FBDR that did not match with inpatient records were more likely 
to die during infancy and were also more likely to be born to Hispanic and NH Black 
mothers. Insurance status was determined by the expected payer listed at hospital discharge, 
because no information was available on the actual payer or whether there were multiple 
payers.
Another limitation of our study was the lack of information related to prenatal diagnoses, 
elective terminations, and clinical care during infancy. A prenatal diagnosis provides more 
time to plan optimal in utero and urgent postnatal surgical management, although the 
positive impact of a prenatal diagnosis has not been firmly established.50–52 Infants with 
more severe types of CHDs might be more likely to be electively terminated when 
prenatally diagnosed53–55; thus, differential access to prenatal care because of health 
insurance type and cultural predisposition toward prenatal testing and pregnancy termination 
might affect the survival likelihood of the live birth cohort.56,57 Although not available for 
this analysis, the quality of hospital and surgical care played an important role in survival. 
Because health insurance also influenced access and use of specific facilities and health care 
providers, caution should be used against overadjustment of the quality of care when 
considering the association between survival and insurance because of its role as an 
intermediate variable in the causal pathway.58
Our study improved on previous studies in 4 important areas. First, the period of observation 
for each infant was not restricted to a single encounter within the health care system; 
therefore, we were able to observe the impact of health insurance status on the entire infant 
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survival experience. Second, a more robust categorization of insurance status was 
determined because we had information on all Florida hospitalizations during infancy and 
were able to identify those infants who changed insurance types during the first year of life. 
Third, the data used in our study were unique in that they combined individually linked and 
de-duplicated data from a state-wide, population-based birth defects surveillance program 
with linked, longitudinal hospitalization data. Fourth, the large population size and racial/
ethnic diversity allowed for more detailed stratifications that revealed complex relations 
between insurance type and survival. We also illustrated how birth defects surveillance data, 
in combination with other administrative data sets, could be used to examine survival among 
infants with CHD, including critical and noncritical CHDs.
Conclusions
In our state-wide study population of infants with CHDs, those with no or insufficient health 
care coverage had a significantly higher risk of neonatal death, indicating that lack of health 
insurance was a potential barrier to appropriate and life-saving medical treatment. Although 
efforts to enroll uninsured infants with CHDs into public insurance plans might reduce 
mortality, public insurance was associated with a greater post-neonatal mortality risk 
compared with private insurance. This factor deserves greater scrutiny to identify potential 
coverage gaps or other barriers to quality and timely care for publicly insured infants. 
Although health insurance appeared to have a role in the Black–White disparity in survival, 
the growing racial disparities throughout infancy among both the privately and publicly 
insured groups is concerning. Additional examination of the role of insurance type and race/
ethnicity on referral patterns and of socioeconomic indicators is warranted to better 
understand what points of intervention will close the survival gap between insurance types 
and shed better light on the yet unexplained racial/ethnic disparities in survival.
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